Oracle is down 25% year-to-date in 2026, but Wall Street analysts are maintaining a bullish 12-month outlook for ORCL. The analyst optimism implies expectations of a recovery or valuation rerating despite recent equity underperformance, a development that mainly affects stock positioning rather than broader market moves.
Oracle is down 25% year-to-date in 2026, but Wall Street analysts are maintaining a bullish 12-month outlook for ORCL. The analyst optimism implies expectations of a recovery or valuation rerating despite recent equity underperformance, a development that mainly affects stock positioning rather than broader market moves.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment